학술논문

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: Final results and biomarker analysis from an italian oncology group for clinical research (GOIRC) phase II study

Document Type

Article